Clinical Trial Update: Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection [Phase 1]

View source ↗

Summary

Phase 1 safety study of an HBV DNA vaccine for chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBV DNA vaccine (HBV DNA vaccine)

Snippet

Sponsor: PowderMed | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED